Tariffs and trade are not side issues, but a central front in the battle against monopoly power—and for self-government.

AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint ...

With biosimilars to AstraZeneca’s blockbuster rare blood disease med Soliris recently available in the U.S., nonprofit health ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

This monthly report outlines key developments in China’s antitrust sector for April. The following events merit special ...

Patent pool is a consortium of two or more patent-holders to promote a particular technology and share the market ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Insurer EmblemHealth is leading a class-action lawsuit against a subsidiary of AstraZeneca, claiming that the company blocked ...

Tesla’s first-quarter profits plunged by more than two-thirds amid a backlash against Elon Musk’s electric car company that ...

Hungary confirmed that a fifth cattle farm was infected with foot-and-mouth disease in the village of Rabapordany, where 600 cows will be culled, Agriculture Minister Istvan Nagy said in a Facebook ...